Latest Breaking News On - Biontech fosun - Page 1 : comparemela.com

 E-Mail May 1, 2021 - Rheumatologists in Hong Kong joined hands to develop a set of consensus statements on COVID-19 vaccination for local adult patients with autoimmune rheumatic diseases. These timely statements would serve to be a guide for rheumatologists, other specialists, family physicians, specialty nurses, and the public regarding COVID-19 vaccination for patients with rheumatic diseases. Vaccination against SAR-CoV-2 is a new campaign and a high immunization rate is believed to be the key to end the pandemic. Currently, there are two COVID-19 vaccines available in Hong Kong the inactivated virus vaccine CoronaVac® (Sinovac) and the mRNA-based vaccine Comirnaty® (BioNTech/Fosun). However, due to the paucity of experience in patients with autoimmune rheumatic diseases, there are concerns from patients regarding the efficacy and safety of the new COVID-19 vaccines. This underscores the importance of input from rheumatologists in providing appropriate advice to patients wi

Tuen munHong kong generalHong kongUnited statesKitty yan kwokRonald yipJulia chanPriscilla wongEdmund liRaymond wongKa lai leeSammas chuLai shan tamCatherine yuenNatalia ciangLydia tam